Since TGFα acts as one of the ligands of the EGFR, and the pancreatic cancer cell lines expressed the receptor (supplementary Fig. 7A), we reasoned that coexpression of the EGFR could facilitate the antiproliferative action of the anti-TGFα ADCs. Here, EGFR is linked to pancreatic neoplasm.